L&G Pharma Breakthrough UCITS ETF
ETLI.DE
#3126
ETF rank
C$27.25 M
Marketcap
๐Ÿ‡ช๐Ÿ‡บ EU
Market
C$19.12
Share price
-0.92%
Change (1 day)
48.36%
Change (1 year)

Expense ratio and fees for L&G Pharma Breakthrough UCITS ETF (ETLI.DE)

Total Expense Ratio

Total Expense Ratio as of November 2025: 0.49%

ter

ter as of April 2026: 0.49%